Skip to main content
Adapt and overcome in response to the Covid-19 crisis
April 23, 2020
MedinCell launches Regulatory Development of mdc-WWM Program
April 22, 2020
Invitation to a webcast: adapting and acting in response to the Covid-19 crisis
April 20, 2020
MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin
April 6, 2020
MedinCell receives $ 6.4 million grant from Unitaid to fight Malaria
March 25, 2020
US Pharma Development Veteran Dr. Richard Malamut Joins the Medical Advisory Board of MedinCell
January 28, 2020
Publication of the activity report and financial information for the first half-year (April – Sept. 2019)
December 3, 2019
The MedinCell General Meeting votes to include the “Raison d’être” of the Company in its articles of association
September 10, 2019
MedinCell receives a new grant to develop a best-in-class long-acting injectable product for HIV PrEP
September 4, 2019
MedinCell partners to address the untapped financial potential in Animal Health
August 28, 2019
